MyFinsight
Home
Blog
About
Contact
Proceeds from maturities
of investments
$75,000K
Net cash provided
(used in) investing...
$27,850K
Canceled cashflow
$47,150K
Net increase
(decrease) in cash and cash...
$6,867K
Canceled cashflow
$20,983K
Purchase of investments
$47,150K
Accounts payable
$2,780K
Stock-based compensation
expense
$2,569K
Prepaid expenses and
other current assets
-$1,571K
Amortization of operating
lease right-of-use...
$331K
Depreciation expense
$26K
Related party payable
$4K
Net cash used in
operating activities
-$20,172K
Net cash used in
financing activities
-$783K
Effect of exchange
rates on cash and cash...
-$28K
Canceled cashflow
$7,281K
Net loss
-$25,408K
Payment of deferred
offering costs
$783K
Accrued expenses and
other current...
-$1,499K
Operating lease liability
-$323K
Net amortization of
premium and discounts on...
-$223K
Back
Back
Cash Flow
Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc. (SPTX)
source: myfinsight.com